share_log

信达证券4月23日发布研报称，给予朗姿股份（002612.SZ）买入评级。评级理由主要包括：1）医美板块收入/盈利能力稳步提升；2）女装直营&线上渠道兑现优异增长；3）婴童潜力赛道依旧保持稳健增长，未来国内市场或为重要增长引擎；4）费率端持续优化推动盈利能力显著提升。（每日经济新闻）

Cinda Securities released a research report on April 23 stating that it gave Langzi Shares (002612.SZ) a purchase rating. The main reasons for the rating include: 1) the steady increase in revenue/profitability of the medical and aesthetic sector; 2) the

Zhitong Finance ·  Apr 23 18:16
Cinda Securities released a research report on April 23 stating that it gave Langzi Shares (002612.SZ) a purchase rating. The main reasons for the rating include: 1) the steady increase in revenue/profitability of the medical and aesthetic sector; 2) the women's clothing direct sales & online channels have achieved excellent growth; 3) the infant potential circuit continues to grow steadily, and the domestic market may be an important growth engine in the future; 4) continuous optimization on the rate side drives a significant increase in profitability. (Mainichi Keizai Shimbun)

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment